Objective. To investigate the pathophysiological effect of immunoglobulin G (IgG) from systemic lupus erythematosus (SLE) patients on pleural mesothelial cells and related mechanisms. Methods. Serum IgG from 28 lupus patients and 13 healthy controls was purified by protein-G affinity chromatography. The concentrations of anti-dsDNA-, anti-histone-and/or anti-nucleohistone-containing IgGs were determined by enzyme-linked immunosorbent assay (ELISA). Lupus patients were divided into an active (n ¼ 12) and an inactive group (n ¼ 16) on the basis of the SLE Disease Activity Index (SLEDAI). The binding of IgG to a human pleural mesothelial cell line (MeT-5A) under different conditions, including pretreatment with DNase and preincubation with exogenous histone, DNA or nucleohistone, was examined using flow cytometry and cellular ELISA. The effect of IgG on MeT-5A cell proliferation was studied using an MTT assay. Gene expression and protein synthesis for interleukin 1b (IL-1b), monocyte chemoattractant protein 1 (MCP-1) and transforming growth factor b1 (TGF-b1) in MeT-5A cells were determined using reverse transcription-polymerase chain reaction and ELISA.
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Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the presence of autoantibodies to various nuclear or cytoplasmic antigens. Antibodies to double-stranded DNA (anti-dsDNA) are found in 40-90% of patients with SLE. Evidence has shown that anti-dsDNA antibodies, particularly of immunoglobulin (Ig) G isotype, play important roles in the pathogenesis of SLE and that a high serum concentration of anti-dsDNA antibodies is closely related to disease activity [1, 2] .
Pleuritis occurs frequently in active lupus and an immunecomplex-mediated mechanism may be a common way in which pleuritis develops. The anti-dsDNA titre is elevated in both serum and pleural fluid from patients with lupus pleuritis [3, 4] . Immunoglobulin deposits are detected in the pleura of patients with lupus pleuritis [5] and DNA-anti-dsDNA immune complexes are present in pleural effusion [6] . Whether tissue immune deposits are derived from circulating immune complexes or are formed in situ remains uncertain. Little is known of any direct pathogenic effect of anti-dsDNA antibodies on pleural mesothelial cells.
Our previous work has shown that anti-DNA antibodies are capable of binding to human glomerular mesangial cells [7] and endothelial cells [8] . The binding of anti-dsDNA antibodies to the endothelial cell can be mediated by either preformed DNAanti-dsDNA immune complexes or by Ig directly [8] . Anti-dsDNA antibodies stimulate the release of cytokines, including interleukin (IL)-1, IL-6, IL-8 and transforming growth factor-(TGF-) from endothelial cells, which could induce endothelial damage [9, 10] . This binding of anti-dsDNA antibodies is mediated by DNA and histone and correlates closely with disease activities [11] .
Furthermore, anti-dsDNA antibodies bind to and stimulate mononuclear cells to produce proinflammatory cytokines such as IL-1, IL-6, IL-8, IL-10 and tumour necrosis factor (TNF-) [12] .
Few studies have focused on the effect of anti-dsDNA antibodies on pleural mesothelial cells. The pleural mesothelial cells are vulnerable to various aetiological agents and participate actively in acute pleural inflammation through cell proliferation and the release of cytokines, including intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), IL-8, monocyte chemoattractant protein 1 (MCP-1), IL-1 and IL-6 [13] . Subsequently, the pleural mesothelial cells play a contributory role in fibroproliferative reactions by releasing fibrogenetic cytokines such as TGF-, platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) [14, 15] .
In this study, we examined the binding of anti-dsDNAcontaining IgG from lupus patients to cultured pleural mesothelial cells (MeT-5A). The possible roles of different antigens, including DNA, histone and nucleohistone, in the binding of anti-dsDNA to MeT-5A cells were tested. We also investigated the effects of antidsDNA antibodies on the proliferation of MeT-5A cells and cytokine synthesis by these cells.
Materials and methods

Patients and controls
The study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee for studies in humans of the University of Hong Kong. All subjects (patients and healthy controls) gave written consent for serum and tissue collection. Serum samples were collected from 28 randomly selected lupus patients (mean age AE S.E.M., 34.8 AE 8.7 yr; 26 females and two males) and 13 healthy controls (30.4 AE 3.9 yr; 12 females and one male). Lupus patients fulfilled four or more diagnostic criteria of the American Rheumatism Association for SLE [16] and they were categorized as 'active' (n ¼ 12) if the SLE Disease Activity Index (SLEDAI) was !10 and 'inactive' (n ¼ 16) if the SLEDAI was 4. Patients with SLEDAI between 4 and 10 were excluded from this study. Of the 12 active patients, two had pleural effusion and two had pleuritic rub. One inactive patient had a small pericardial effusion detected by echocardiography and one had pleural effusion. At the time of serum collection, the active patients had not yet been commenced on treatment and the inactive patients were maintained on low-dose immunosuppressive therapy consisting of prednisolone and azathioprine.
Isolation of IgG
IgG was isolated from sera by protein-G affinity chromatography (Pharmacia, Uppsala, Sweden). The purified IgG was dialysed after centrifugal concentration (Amicon, Beverley, MA, USA). The purity of the IgG antibodies was ascertained by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). The purified IgG was stored at À70 C until use.
Determination of anti-dsDNA, anti-histone and anti-nucleohistone antibodies by ELISA An enzyme-linked immunosorbent assay (ELISA) was developed for the determination of anti-dsDNA, anti-histone and antinucleohistone antibody concentrations in IgG preparations. Calf thymus DNA was obtained from Sigma (St Louis, MO, USA). Histone and nucleohistone (Worthington Biochemical Corporation, Lakewood, NJ, USA) were dissolved in 8 M urea solution and dialysed against phosphate-buffered saline (PBS). Nucleohistone represented nucleosomes containing the nucleoprotein complex of DNA and histones. Briefly, wells of microtitre plates (Immunon 2; Dynatech, Marnes la Coquette, France) were coated with 100 l of calf thymus DNA (10 g/ml), histone (40 g/ml) or nucleohistone (10 g/ml) in 0.015 M sodium carbonate and 0.03 M sodium bicarbonate (pH 9.8) overnight at room temperature. Two hundred microlitres of 3% bovine serum albumin (BSA; Sigma) in TBS was added to each well, and the plates were incubated for 2 h in order to block non-specific binding. After washing, 100 l of serum (diluted 1:100) or purified IgG samples (100 l, 200 g/ml) in TBS (Tris-buffered saline) containing 10% fetal calf serum (Gibco, Chargrin Falls, NY, USA) and 3% BSA were added to each well and the plates were incubated for a further 2 h. After washing, bound Igs were detected using goat anti-human IgG-alkaline phosphatase (Biosource International, Camarillo, CA, USA) conjugated in TBS (1:1000), followed by p-nitrophenyl phosphate (Sigma) as substrate. The optical density (OD) at 405 nm was read on a spectrophotometer and the concentration of anti-dsDNA antibodies was then determined according to a standard curve constructed using the international standard. The anti-histone and anti-nucleohistone levels were expressed as OD at 450 nm (A 450 ).
Cell culture
The pleural mesothelial cell line (MeT-5A) was obtained from the American Type Culture Collection (Rockville, MD, USA). The cells were maintained with RPMI 1640 culture medium (Gibco) containing 10% fetal calf serum, 100 U/ml penicillin and 100 g/ml streptomycin in an atmosphere and 5% CO 2 /95% room air at 37 C. Subculture or preparation of cells for assay was done when the cells reached confluence.
Reverse transcription-polymerase chain reaction
MeT-5A cells were grown to confluence in six-well cell culture plates, growth-arrested, and exposed to IgG for defined time periods at 37 C. Total cellular RNA was then extracted and reverse-transcribed to cDNA. The polymerase chain reaction (PCR) was carried out as described previously [12] . The oligonucleotide sequences of cDNA primers were designed from GenBank sequences. The primer sequences and PCR profiles for amplifying the various target genes and their product sizes are summarized in Table 1 . For quantification, human glyceraldehyde 3-phosphatedehydrogenase (GAPDH) primers were included in every reaction as an internal control. The PCR products were separated by 2% weight/volume agarose gels and stained with ethidium bromide (Sigma), and the gel image was captured and analysed using the Gel Doc 1000 Densitometry System and Quantity One (Bio-Rad Laboratories, Hercules, CA, USA). The PCR result was expressed as an amplicon ratio with respect to GAPDH.
Binding of IgG to MeT-5A cells by flow cytometry
MeT-5A cells were grown to confluence and were harvested using 0.05% trypsin for 5 min at room temperature and then fixed in 1% paraformaldehyde (PFA) at 4 C for 15 min. One hundred microlitres of MeT-5A cells (5 Â 10 5 cells/ml) in staining buffer (PBS with 1% fetal bovine serum and 0.1% sodium azide) was mixed with purified IgG (200 g/ml) from the active or inactive SLE group or the healthy controls and incubated for 30 min at 4 C. After washing with ice-cold staining buffer, 50 l of rabbit F(ab 0 ) 2 anti-human IgG-FITC (fluorescein isothiocyanate) conjugate (Dako, Glostrup, Denmark) at 50-fold dilution was added and cells were further incubated for 30 min. Cells were spun down, resuspended with 250 l of 1% PFA and analysed by flow cytometry on a Coulter EPICS analyser (Coulter Electronic, Miami, FL, USA). A minimum of 5000 cells for each sample were analysed. The result was expressed as mean fluorescence intensity (MFI).
For some experiments, MeT-5A cells were treated with DNase (50 g/ml) in Tris-MgCl 2 (10 mM) at 37 C for 15 min before the binding assay, to examine the effect of cell surface-bound DNA on cell binding of IgG. To study the effects of exogenous DNA, histone, or nucleohistone on IgG binding to MeT-5A cells, the cells were preincubated with different concentrations of DNA, histone or nucleohistone (0-5 mg/ml) at room temperature for 30 min before the binding experiment. In order to study whether the binding of IgG was Fc-dependent, F(ab 0 ) 2 fragments of IgG were prepared by pepsin digestion. Briefly, purified IgG was digested using immobilized pepsin (Pierce, Rockford, IL, USA) at 37 C for 4 h in a shaking water bath. The F(ab 0 ) 2 fragments were separated from the Fc portion and undigested IgG by protein-G affinity chromatography (Pharmacia, Uppsala, Sweden). The binding of F(ab 0 ) 2 fragments of IgG to MeT-5A cells was determined by flow cytometry, as described above.
Inhibition assay of cell binding by cellular ELISA
MeT-5A cells at the log phase were harvested and seeded in 96-well culture plates until confluence. MeT-5A cells were fixed with 1% PFA for 10 min and blocked with 3% BSA (bovine serum albumin) at 4 C overnight. In order to see if DNA, histone or nucleohistone could block the binding of IgG to MeT-5A cells, IgG (100 l, 200 g/ml), before incubation with MeT-5A cells, was coincubated with DNA (1 mg/ml), histone (1 mg/ml) or nucleohistone (1 mg/ml) in 100 l of TBS for 1 h. The plates were then incubated for 2 h at room temperature. After three washes with 200 l of TBS per well, 100 l of goat F(ab 0 ) 2 anti-human IgG-horseradish peroxidase conjugate was added and the plates were further incubated for 1 h. After washing, o-phenylenediamine (OPD) was added and the OD at 450 nm was determined. MeT-5A cells were seeded in each well of 96-well polystyrene plates. The cells were arrested with serum-free medium 1 day before the experiment. Purified IgG (final concentration 200 g/ml) was added to the wells and the plate was incubated at 37 C in 5% CO 2 for half an hour. Ten microlitres of MTT reagent was added to each well and the plate was incubated at 37 C until purple-blue crystals were clearly visible under an inverted microscope. Detergent reagent (100 l; R&D Systems, Minneapolis, MN, USA) was then added and the plate was incubated at 37 C for 4 h. The OD of the wells was read at 550 nm with a reference wavelength of 650 nm.
Proliferation studies by MTT assay
Immunoassay for cytokines in cell culture supernatant
MeT-5A cells were grown to confluence in six-well culture plates. The cultured cells were arrested with serum-free medium for 48 h before the experiment. The cells were incubated with IgG from SLE patients or healthy controls for 16 h at 37 C. Culture supernatant was collected and the concentrations of TGF-1, MCP-1 or IL-1 were measured using an ELISA kit (TGF-1, R&D Systems; MCP-1, Chemicon, Temecula, CA, USA; IL-1, MedSystem Diagnostics, Vienna, Austria) according to the manufacturers' protocols. The sensitivity of the assay was 7, 13.1 and 1.5 pg/ml for TGF-1, MCP-1 and IL-1 respectively. The intra-batch coefficient of variation was 5.2% for TGF-1, 7.9% for MCP-1 and 8% for IL-1.
Statistical analysis
The results were expressed as mean AES.D. when the normal distribution could be assumed, otherwise as median and range. Differences in parameters between groups were evaluated either by analysis of variance or the Kruskal-Wallis test, as appropriate. Correlations between different study variables were detected by Spearman's correlation test. P < 0.05 was considered significant. The analysis was performed with the SPSS 10.0 statistical package.
Results
Characterization of purified IgG preparations
The concentration of anti-dsDNA antibodies in purified IgG from the lupus patients (median 30 IU/ml, range 4.0-1690 IU/ml) was higher than that for the healthy controls (median 14.4 IU/ml, range 4.0-41.9 IU/ml, P < 0.001). Amongst the lupus patients, the concentrations of anti-dsDNA antibodies were significantly greater in the active group than in the inactive group (median 56.7 IU/ml, range 44.6-1690 IU/ml vs median 14.3 IU/ml, range 4.4-42.3 IU/ml; P < 0.001) (Fig. 1) . The anti-histone antibody level in the active SLE group was higher than that in the inactive SLE group (A 450 0.563 AE 0.142 vs 0.441 AE 0.059; P ¼ 0.015). The anti-histone antibody level in the active SLE group was also higher than that in the control group (A 450 0.563 AE 0.142 vs 0.423 AE 0.103; P ¼ 0.011). There was no difference in the anti-histone antibody level between the inactive 
Binding of IgG to MeT-5A cells and effect of DNase treatment on binding
The binding of IgG to MeT-5A cells (expressed as the MFI) was higher in the active SLE group than in the inactive SLE group (MFI 0.894 AE 0.238 vs 0.717 AE 0.088; P ¼ 0.047). There was also a significant difference in binding between the active SLE group and the healthy controls (MFI 0.894 AE 0.238 vs 0.599 AE 0.039; P ¼ 0.003).
After treating the MeT-5A cells with DNase, the binding was decreased in both the active SLE group (no DNase treatment 0.894 AE 0.238, DNase treatment 0.778 AE 0.152; P ¼ 0.018) and the inactive SLE group (no DNase treatment 0.717 AE 0.088, DNase treatment 0.668 AE 0.079; P ¼ 0.002). Such a difference was not observed with IgG isolated from healthy controls (no DNase treatment 0.599 AE 0.035, DNase treatment 0.574 AE 0.039; P > 0.05) (Fig. 2) .
Binding of IgG to MeT-5A cells preincubated with exogenous histone, nucleohistone or DNA The binding of IgG from patients with active lupus to MeT-5A cells increased by 112% after preincubation with histone (histone preincubation 1.555 AE 0.134, no histone preincubation 0.735 AE 0.262; P < 0.001). The increase in binding after histone preincubation was concentration-dependent in the active lupus group (Figs 3 and 4) . A similar increase in binding after histone preincubation was not observed in patients with inactive lupus or in healthy controls. In contrast, the binding of IgG to MeT-5A cells was not enhanced by preincubation with exogenous DNA or nucleohistone (Fig. 3) .
Effects of coincubated exogenous histone, nucleohistone and DNA on binding of IgG to MeT-5A cells
In neither the active nor the inactive SLE group was a significant difference observed in the binding of IgG to MeT-5A cells when IgG was coincubated with exogenous DNA, histone or nucleohistone (Fig. 5) .
Binding of pepsin-digested IgG to MeT-5A cells
Following the pepsin digestion, the binding of F(ab 0 ) 2 fragment of IgG to MeT-5A cells remained significantly higher in the active SLE group (MFI 0.76 AE 0.21) than in the inactive SLE group (0.54 AE 0.09) and the healthy controls (0.47 AE 0.10) (P ¼ 0.0098 and P ¼ 0.002 respectively). No significant difference was found between the inactive SLE group and the healthy controls (Fig. 6 ).
Effect of IgG on MeT-5A cell proliferation
The proliferation index was expressed as MTT conversion, which was determined as OD at 550 nm. The proliferation index of the (Fig. 7) .
Effect of IgG on differences in cytokine gene expression and synthesis by MeT-5A cells
Expression of the MCP-1, TGF-1 and IL-1 genes in cultured MeT-5A cells is shown in Figs 8A, 9A and 10A. The expression of MCP-1 mRNA in MeT-5A cells incubated with IgG from the active SLE group (2.45 AE 1.05) was significantly higher than that in MeT-5A cells incubated with IgG from the inactive SLE group (0.69 AE 0.29, P < 0.001) and the healthy controls (0.92 AE 0.21, P < 0.001). Similarly, expression of the TGF-1 gene in MeT-5A cells incubated with IgG from the active SLE group was higher than that in cells incubated with IgG from the inactive SLE group (1.18 AE 0.10 vs 0.91 AE 0.12; P < 0.001) or control IgG (1.18 AE 0.10 vs 1.05 AE 0.07; P ¼ 0.007). For IL-1 gene expression, there was a significant increase in MeT-5A cells incubated with IgG from the active SLE group compared with cells incubated with IgG from healthy controls (1.13 AE 0.145 vs 0.94 AE 0.10; P ¼ 0.006). However, no significant difference in IL-1 gene expression was observed between the active and inactive SLE groups (1.13 AE 0.145 vs 1.02 AE 0.24; P > 0.05).
The concentrations of MCP-1, TGF-1 and IL-1 in culture supernatants of MeT-5A cells stimulated with different IgG preparations are shown in Figs 8B, 9B and 10B. IgG from patients with active lupus enhanced the synthesis of MCP-1 in MeT-5A cells (97.60 AE 8.49 pg/ml) compared with IgG from either the inactive lupus group (67.08 AE 16.10 pg/ml) and healthy controls (58.86 AE 19.24 pg/ml) (P < 0.001). In parallel with the gene expression, there was increased synthesis of TGF-1 in MeT-5A cells incubated with IgG from active lupus subjects (67.31 AE 11.95 pg/ml) compared with values from the inactive lupus group (15.29 AE 13.26 pg/ml, P < 0.001) and the healthy controls (32.49 AE 16.53 pg/ml, P < 0.001). The synthesis of IL-1 by MeT-5A cells was significantly higher after incubation with IgG from the active SLE (682.40 AE 233.59 pg/ml) than after incubation with IgG from the inactive SLE group (385.40 AE 135.67 pg/ml, P ¼ 0.003) or the healthy controls (288.10 AE 54.26 pg/ml, P < 0.001). 
Correlation analysis
The binding of IgG from the patients with SLE to MeT-5A cells correlated with the serum concentrations of anti-dsDNA (r ¼ 0.615, P < 0.001) and anti-histone antibodies (r ¼ 0.375, P ¼ 0.034) but not with the concentration of anti-nucleohistone antibodies.
The concentration of anti-dsDNA antibodies correlated with the gene expression of MCP-1 (r ¼ 0.578, P ¼ 0.001), TGF-1 (r ¼ 0.409, P ¼ 0.029) and IL-1 (r ¼ 0.422, P ¼ 0.028) by MeT-5A cells. There was also a positive correlation between anti-histone antibody titre and MCP-1 gene expression (r ¼ 0.386, P ¼ 0.043), but not with TGF-1 or IL-1 gene expression Similar findings were observed with respect to the correlation between anti-dsDNA antibody titre and the MeT-5A cell supernatant concentrations of MCP-1 (r ¼ 0.578, P ¼ 0.001), TGF-1 (r ¼ 0.637, P < 0.001) and IL-1 (r ¼ 0.616, P < 0.001). Again, there was an association between anti-histone antibody titre and the synthesis of MCP-1 (r ¼ 0.368, P ¼ 0.046) but not with TGF-1 or IL-1.
There was a good correlation between gene expression and protein synthesis by MeT-5A cells for MCP-1 (r ¼ 0.68, P < 0.001) and for TGF-1 (r ¼ 0.565, P ¼ 0.003). Such correlation was not observed with IL-1.
Discussion
Previous studies have shown that anti-dsDNA antibodies bind to endothelial and glomerular mesangial cells [7] [8] [9] . The binding of anti-dsDNA antibodies to endothelial or mesangial cells is increased in active disease, vasculitis or lupus nephritis, suggesting that the binding of these antibodies to target cells may play a direct pathogenic role [8] [9] [10] . In lupus patients with pleuritis, the antidsDNA antibody titre is raised in both serum and pleural fluid [3] and DNA-anti-dsDNA immune complexes are detected in pleural fluid [6] . However, little is known about the interaction of polyclonal IgG anti-dsDNA antibodies with pleural mesothelial cells and their pathogenic roles in lupus pleuritis. This is the first study to explore the direct pathogenic effect of anti-dsDNAcontaining IgG isolated from patients with SLE in a pleural mesothelial cell line. An immortalized cultured cell line was used in the present study because the use of primary human pleural mesothelial cells obtained from pleural effusion by thoracentesis has drawbacks as an in vitro model. These include (i) difficulty in obtaining a consistent supply of human pleural effusion with a sufficient number of pleural mesothelial cells; (ii) batch-to-batch inconsistency due to donor variation; (iii) potential activation of pleural mesothelial cell obtained from disease-induced effusion; and (iv) the slow growth rate of human primary pleural mesothelial cells.
Our present findings show that IgG from patients with SLE is, indeed, able to bind to pleural mesothelial cells. The binding of IgG from the active lupus group was significantly stronger than that of IgG from either the inactive lupus or the control group, suggesting that this binding is closely related to disease activity. After pepsin digestion, the binding of IgG F(ab 0 ) 2 fragments of antibodies from the active lupus group was still higher than that of IgG from the inactive lupus or control group; this is similar to what occurred with undigested IgG. Our result indicates that, unlike the binding of antibodies to glomerular basement membrane (GBM) through the Fc fragment [17] , the binding of IgG to MeT-5A cells is dependent on the F(ab 0 ) 2 fragment. Reduction of binding by IgG isolated from lupus patients after DNase treatment of MeT-5A cells indicates that DNA on the cell surface is essential in the binding of anti-dsDNA-containing IgG to various cell types, including pleural mesothelial cells. Our previous study showed that the binding of the anti-dsDNA antibodies to endothelial cells was influenced by histone and DNA [11] . Results from the present study demonstrate that IgG from active lupus patients contains a raised level of anti-histone antibodies with high binding activity to MeT-5A cells. This is consistent with other work suggesting that anti-histone antibodies are associated with disease activity in lupus nephritis [18] . We further showed that preincubation of histone with MeT-5A cells increased the binding of IgG from active lupus patients to MeT-5A cells in a concentration-dependent fashion. It has been demonstrated that cell-surface proteoglycans, such as perlecan, can interact with histone molecules [19] . We speculate that the enhancement of binding after preincubation of MeT-5A cells with histone could be due to the immobilization of histone with DNA or other proteins present on the cell membrane of MeT-5A cells. Anti-histone-containing IgG will then bind to the immobilized histone. The binding of IgG to MeT-5A cells remained unchanged when IgG was coincubated with histone. This could have been due to the steric hindrance of the binding of the exogenous histone with proteoglycans on the cell membrane after the formation complexes between exogenous histone and anti-histone antibodies. Further investigation is warranted to confirm this hypothesis.
Several studies have shown that nucleosome-specific antibodies can be detected before the occurrence of the anti-dsDNA or antihistone antibodies in the lupus-prone mouse, and that the antibodies continue to exist during the course of the disease along with the anti-dsDNA and anti-histone antibodies [20, 21] . It has also been suggested that nucleosomes play an essential role in the development of lupus nephritis by targeting antinuclear antibodies to mesangial cells [22] . The monoclonal nucleosomespecific antibodies bind to the rat GBM only when complexed to nucleosomes, but not to antibodies alone [23] . Despite the importance of anti-nucleohistone antibodies in SLE suggested by a previous study [24] , we failed to demonstrate increased cell proliferation or cytokine release by MeT-5A cells after binding to anti-nucleohistone antibodies. We also found that preincubating MeT-5A cells with nucleohistones did not result in any enhancement of binding of IgG from lupus patients. We speculate that the ineffectiveness of nucleohistone in the binding of IgG from SLE patients to MeT-5A was due to (i) lack of significant differences in the anti-nucleohistone levels between active SLE, inactive SLE and healthy controls groups, and (ii) the neutral pI of 6.9 in nucleosomes formed by combining histone (with the cationic N-terminal portion) and DNA of an anionic nature [25] . The cationic region of the nucleosome can be further neutralized after binding with anti-histone antibodies, which affect binding to negatively charged proteins on the cell surface.
Pleural mesothelial cells participate in acute pleural inflammation and the specific immunity is regulated through cell proliferation and the release of cytokines, including IL-1, TGF-1 and MCP-1 [13, 14] . We demonstrated that IgG from active lupus patients significantly induced the gene expression and protein synthesis of IL-1, TGF-1 and MCP-1 when compared with IgG from the inactive lupus or healthy control group. Moreover, the synthesis of these cytokines correlated well with the anti-dsDNA antibody titre. The purified IgG preparations used in our in vitro studies were free of complement or cytokines that could activate MeT-5A cells [26, 27] . Our findings suggest that a direct upregulatory effect of anti-dsDNA antibodies on cytokine production is a possible pathogenetic mechanism of pleural mesothelium injury in SLE. The direct binding of anti-DNA antibodies to proteins on the cell surface membrane or nuclei leads to altered cell functions, including proliferation, apoptosis and protein synthesis [28] [29] [30] . It is likely that the proliferation of MeT-5A cells is due to the direct binding of anti-DNA-containing IgG to DNA or negatively charged protein on the cell membrane. It has been shown that extracellular histone bound to perlecan stimulates myoblast proliferation [19] . Proteoglycans on the cell surface may mediate the internalization of histone and induce cell proliferation [19] . Nonetheless, whether similar mechanism(s) operate after binding of anti-DNA to MeT-5A cells remains to be explored.
In conclusion, we have provided in vitro evidence that the binding of autoantibodies from active lupus patients to MeT-5A cells is closely associated with disease activity. The binding of these antibodies to MeT-5A cells is mediated by DNA and histone. Anti-dsDNA antibodies exert a direct pathogenic effect in lupus pleuritis by stimulating the production of proinflammatory cytokines after binding to the pleural mesothelial cells.
